US Drug Recall Register
Class III · Low risk Terminated Initiated Aug 5, 2016 (10 years ago)

Claravis

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications.

What was recalled

Claravis (isotretinoin capsules USP), 10mg, packaged in carton containing 3 Blister Packs of 10 Capsules Each (30 Capsules total); Rx only, TEVA PHARMACEUTICALS USA, Sellersville, PA 18960. NDC 00555-1054-86

Recalling firm
Teva North America
NDC code
00555-1054-86
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0005-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Isotretinoin recalls

See all
Class II · Moderate risk Ongoing

Claravis

Reason Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin

Teva Pharmaceuticals USA, Inc NDC 0555-1054-56 D-0521-2026
Class II · Moderate risk Ongoing

Amnesteem

Reason Failed Dissolution Specifications

Mylan Pharmaceuticals INC NDC 0378-6614-93 D-0399-2026
Class II · Moderate risk Ongoing

Isotretinoin Capsules

Reason Superpotent and Subpotent

Teva Pharmaceuticals USA, Inc NDC 0591-2436-15 D-0446-2026
Class II · Moderate risk Ongoing

Isotretinoin Capsules

Reason Superpotent and Subpotent

Teva Pharmaceuticals USA, Inc NDC 0591-2435-15 D-0445-2026
Class II · Moderate risk Ongoing

Isotretinoin Capsules

Reason Superpotent Drug: The 3-month stability result for assay was found to be above specification limit

Teva Pharmaceuticals USA, Inc NDC 0591-2436-45 D-0439-2024